摘要
背景:一些全基因组关联研究已经发现rs11136000 C等位基因与多态性(CLU-C)联系在一起,发展成晚发型阿尔茨海默氏症的风险(负载)。然而,CLU-C / C基因型的影响大脑结构,包括灰色和白色物质,没有充分解释。 目的:我们旨在澄清的灰质和白质完整性变化非痴呆患者老龄化rs11136000的阿尔茨海默病风险基因C等位基因的多态性与认知(CLU-C)的相关性能。 方法:用于比较的差异分布分析高分辨率结构之间的T1和扩散张量成像数据31 CLU-C C / C和15 non-CLU-C /运营商nondemented老年人。 结果:non-CLU-C / C运营商相比,CLU-C该显示灰质浓度降低(GMC)在左侧海马旁回、右侧中间额叶和颞脑回中,GMC在左额中增加和右梭状脑回和增加灰质体积(GMV)在左额中(P < 0.001)。降低分数各向异性(FA)sub-gyral白质的左外部胶囊和左前扣带和增加FA sub-gyral左颞叶白质也发现CLU-C / C基因型携带者。此外,FA值在左外部胶囊中有几个认知措施。 结论:我们的研究结果提供进一步证据,CLU风险变异作为阿尔茨海默病的候选基因,可能作为临床前神经影像表型的迟发性的阿尔茨海默病。
关键词: 老化、老年痴呆症、clusterin(俱乐部)、扩散张量成像、神经影像学、分布形态测量学。
Current Alzheimer Research
Title:Genetically-mediated Grey and White Matter Alteration in Normal Elderly Individuals with the CLU-C Allele Gene
Volume: 13 Issue: 11
Author(s): Lihua Qiu, Yong He, Hehan Tang, Yi Zhou, Jinhong Wang, Weiwei Zhang, Guangxiang Chen, Fei Zhao, Tingxue Ouyang, Bin Ju and Zhengyan Li, Lanlan Wang, Ling Zou, Qiyong Gong
Affiliation:
关键词: 老化、老年痴呆症、clusterin(俱乐部)、扩散张量成像、神经影像学、分布形态测量学。
摘要: Background: Several genome-wide association studies have found that the rs11136000 polymorphism of the C allele (CLU-C) is associated with the risk for developing late-onset Alzheimer’s disease (LOAD). However, the effects of the CLU-C/C genotype on brain structure, including gray and white matter, are not adequately understood.
Objectives: We aimed to clarify the gray matter and white matter integrity changes in non-demented ageing individuals with the AD risk gene of the rs11136000 polymorphism of the C allele (CLU-C) and the correlation with cognitive performance.
Methods: Voxel-based analysis was used to compare the differences in high-resolution structural T1 and diffusion tensor imaging data between 31 CLU-C/C and 15 non-CLU-C/C carriers in nondemented older adults.
Results: Compared to non-CLU-C/C carriers, CLU-C homozygotes showed a reduced gray matter concentration (GMC) in the left parahippocampal gyrus, right middle frontal and temporal middle gyri, increased GMC in the left middle frontal and right fusiform gyri and increased gray matter volume (GMV) in the left middle frontal gyrus (P < 0.001). Decreased fractional anisotropy (FA) in the sub-gyral white matter of the left external capsule and left anterior cingulate and increased FA in the sub-gyral white matter of the left temporal lobe were also found in CLU-C/C genotype carriers. Moreover, the FA value in the left external capsule correlated with several cognitive measures.
Conclusion: Our findings provide further evidence for the CLU risk variant as a candidate gene for AD and may serve as a pre-clinical neuroimaging phenotype of late-onset AD.
Export Options
About this article
Cite this article as:
Lihua Qiu, Yong He, Hehan Tang, Yi Zhou, Jinhong Wang, Weiwei Zhang, Guangxiang Chen, Fei Zhao, Tingxue Ouyang, Bin Ju and Zhengyan Li, Lanlan Wang, Ling Zou, Qiyong Gong , Genetically-mediated Grey and White Matter Alteration in Normal Elderly Individuals with the CLU-C Allele Gene, Current Alzheimer Research 2016; 13 (11) . https://dx.doi.org/10.2174/1567205013666160703180531
DOI https://dx.doi.org/10.2174/1567205013666160703180531 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy
Recent Patents on Anti-Cancer Drug Discovery Impact of the Somatotrope Growth Hormone (GH)/Insulin-Like Growth Factor 1 (IGF-1) Axis Upon Thymus Function: Pharmacological Implications in Regeneration of Immune Functions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Role of Insulin-Like Growth Factor I Components in the Regulation of Vitamin D
Current Pharmaceutical Biotechnology Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
Anti-Cancer Agents in Medicinal Chemistry HIV-1 Replication and Pathogenesis in the Human Thymus
Current HIV Research Subject Index
Current Signal Transduction Therapy Editorial [Hot topic: Central and Peripheral Metabolic Changes in Neurodegenerative Diseases (Guest Editor: Ana Cristina Rego)]
Current Drug Targets Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials
Current Pharmaceutical Design Interpersonal-Psychological Precursors to Suicidal Behavior: A Theory of Attempted and Completed Suicide
Current Psychiatry Reviews QT Prolongation and Anticancer Drugs: Is it a Cardiologist’s Worry? The Oncologist’s Point of View
Reviews on Recent Clinical Trials Importance of P-gp PET Imaging in Pharmacology
Current Pharmaceutical Design The Multifunctional Protein C System
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Strain Imaging Echocardiography: What Imaging Cardiologists Should Know
Current Cardiology Reviews Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Management of Glia-Mediated Neuroinflammation and Related Patents
Recent Patents on Inflammation & Allergy Drug Discovery Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells
Current Stem Cell Research & Therapy